We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+23.77%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$58.1B
AUM Growth
+$9.39B
Cap. Flow
-$245M
Cap. Flow %
-0.42%
Top 10 Hldgs %
13.23%
Holding
2,444
New
480
Increased
936
Reduced
725
Closed
86

Sector Composition

Rank Sector Weight
1 Healthcare 16.96%
2 Technology 16.82%
3 Financials 13.96%
4 Industrials 9.56%
5 Communication Services 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPWK icon
2026
Upwork
UPWK
$1.09B
$28K ﹤0.01%
+1,942
New +$20.4K
WIRE
2027
DELISTED
Encore Wire Corp
WIRE
$28K ﹤0.01%
+567
New +$26K
CADE
2028
DELISTED
Cadence Bancorporation
CADE
$28K ﹤0.01%
+3,118
New +$22.3K
ADT icon
2029
ADT
ADT
$5.16B
$27K ﹤0.01%
+3,362
New +$21.7K
AX icon
2030
Axos Financial
AX
$5.45B
$27K ﹤0.01%
+1,245
New +$25.3K
GOSS icon
2031
Gossamer Bio
GOSS
$66.5M
$27K ﹤0.01%
+2,058
New +$25.9K
HSII
2032
DELISTED
Heidrick & Struggles
HSII
$27K ﹤0.01%
1,230
-6,670
-84% -$147K
LNN icon
2033
Lindsay Corp
LNN
$1.16B
$27K ﹤0.01%
+292
New +$26.8K
LRN icon
2034
Stride
LRN
$3.69B
$27K ﹤0.01%
1,000
MTRN icon
2035
Materion
MTRN
$5.01B
$27K ﹤0.01%
+442
New +$22.4K
QNCX icon
2036
Quince Therapeutics
QNCX
$17.5M
$27K ﹤0.01%
+3
New +$27.5K
RMR icon
2037
The RMR Group
RMR
$342M
$27K ﹤0.01%
922
-4,078
-82% -$118K
SMCI icon
2038
Super Micro Computer
SMCI
$19.5B
$27K ﹤0.01%
9,640
-224,530
-96% -$565K
SONO icon
2039
Sonos
SONO
$1.75B
$27K ﹤0.01%
+1,871
New +$19.9K
TCRT icon
2040
Alaunos Therapeutics
TCRT
$4.74M
$27K ﹤0.01%
+54
New +$24.1K
UIS icon
2041
Unisys
UIS
$227M
$27K ﹤0.01%
+2,462
New +$28.5K
GTHX
2042
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$27K ﹤0.01%
+1,100
New +$18.2K
KAMN
2043
DELISTED
Kaman Corp
KAMN
$27K ﹤0.01%
+639
New +$24.7K
CNST
2044
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$27K ﹤0.01%
+896
New +$32.3K
BSTC
2045
DELISTED
BioSpecifics Technologies Corp.
BSTC
$27K ﹤0.01%
440
-2,360
-84% -$137K
AIMT
2046
DELISTED
Aimmune Therapeutics
AIMT
$27K ﹤0.01%
+1,618
New +$27.5K
DLPH
2047
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$27K ﹤0.01%
+1,903
New +$21.3K
BKE icon
2048
Buckle
BKE
$2.19B
$26K ﹤0.01%
+1,654
New +$24.8K
CBZ icon
2049
CBIZ
CBZ
$2.29B
$26K ﹤0.01%
1,081
-3,771
-78% -$85.6K
CIGI icon
2050
Colliers International
CIGI
$4.98B
$26K ﹤0.01%
446

Similar funds

Macquarie Group's Q2 2020 Portfolio in Review

As of Q2 2020, Macquarie Group held 2,444 positions worth $58.1B, up 19% from $48.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Macquarie Group's Q2 2020 filing shows 480 new, 936 increased, 725 reduced and 86 closed positions. Its largest new stake was LGI Homes: 1,071,112 shares worth $94.3M. The largest sale was Raytheon Company, an estimated $529M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Macquarie Group's largest Q2 2020 buy was LGI Homes: 1,071,112 shares worth $94.3M.
  • Macquarie Group added most to RTX Corp in Q2 2020, an estimated $647M increase.
  • Macquarie Group's biggest Q2 2020 reduction was Occidental Petroleum, cutting an estimated $321M.
  • Macquarie Group fully exited Raytheon Company in Q2 2020, selling an estimated $529M.
  • Macquarie Group's ten largest holdings make up 13% of its $58.1B portfolio in Q2 2020.
  • Macquarie Group opened 480 new positions and closed 86 in Q2 2020.
  • Macquarie Group's portfolio value rose 19% quarter-over-quarter to $58.1B.

Based on Macquarie Group's 13F filing for Q2 2020, filed 11 Aug 2020.